Total loss of HLA-A was observed in 14 CRC samples (10.6%), partial loss was observed in 7 samples (5.3%), and a mixed positive and negative expression of HLA-A was identified in 3 samples (Figures 1B, C). This evidence concerns the gene HLA-A and colorectal carcinoma.